Akt fine-tunes NF-κB-dependent gene expression during T cell activation

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• The Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway is vital for immune cell function.
• The Akt kinase's role in linking T cell receptor (TCR) and CD28 signaling to NF-κB activation remains incompletely understood.

Purpose of the Study:

• To elucidate the specific role of Akt kinase in regulating NF-κB-dependent gene expression during T cell activation.
• To investigate how Akt influences the formation of key signaling complexes and subsequent gene transcription.

Main Methods:

• Targeted gene profiling to identify Akt-dependent NF-κB genes.
• Analysis of mRNA transcription and p65/RelA promoter binding.
• Assessment of Carma1-Bcl10 complex formation.
• Inhibition and knockdown studies of Akt, including in primary human T cells and a mouse model of rheumatoid arthritis.

Main Results:

• A subset of NF-κB-dependent genes requires Akt for optimal induction during T cell activation.
• Akt influences mRNA transcription and p65/RelA binding, mediated by altered Carma1-Bcl10 complex formation.
• Tumor Necrosis Factor-alpha (TNF-α) expression is highly sensitive to Akt inhibition or knockdown.

Conclusions:

• Akt kinase acts as a critical regulator in a hierarchy of NF-κB-dependent gene expression, influenced by signaling strength and duration.
• Understanding graded signaling effects, like those of Akt on the NF-κB pathway, is essential for comprehending cellular response fine-tuning for sensitivity and specificity.
• These findings have implications for inflammatory diseases, particularly those involving TNF-α, such as rheumatoid arthritis.